RE: Effect of the dual 5alpha-reductase inhibitor dutasteride on markers of tumor regression in prostate cancer.
Pitts
W Reid
WR
D058891:5-alpha Reductase Inhibitors; D017209:Apoptosis; D001378:Azasteroids / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000032:analysis; D013196:Dihydrotestosterone / Q000037:antagonists & inhibitors; D000068538:Dutasteride; D018120:Finasteride / Q000627:therapeutic use; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D013739:Testosterone / Q000378:metabolism
D058891:5-alpha Reductase Inhibitors; D001378:Azasteroids; D014408:Biomarkers, Tumor; D013196:Dihydrotestosterone; D013739:Testosterone; D018120:Finasteride; D000068538:Dutasteride